WO2023174449A1 - Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide - Google Patents

Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide Download PDF

Info

Publication number
WO2023174449A1
WO2023174449A1 PCT/CN2023/094292 CN2023094292W WO2023174449A1 WO 2023174449 A1 WO2023174449 A1 WO 2023174449A1 CN 2023094292 W CN2023094292 W CN 2023094292W WO 2023174449 A1 WO2023174449 A1 WO 2023174449A1
Authority
WO
WIPO (PCT)
Prior art keywords
chloro
pyridylmethoxy
phenyl
cyanoacetamide
preparation
Prior art date
Application number
PCT/CN2023/094292
Other languages
French (fr)
Chinese (zh)
Inventor
岳永力
沈艳阳
饶经纬
鲁飞
林立
柯尚峰
Original Assignee
安庆朗坤药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 安庆朗坤药业有限公司 filed Critical 安庆朗坤药业有限公司
Publication of WO2023174449A1 publication Critical patent/WO2023174449A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the invention belongs to the field of medicinal chemistry, and specifically relates to a preparation method of pharmaceutical intermediate N-(3-chloro-4-(2-pyridinemethoxy)phenyl)-2-cyanoacetamide.
  • N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide (CAS: 915945-31-2) is a HER-2 receptor tyrosine kinase inhibitor Important pharmaceutical intermediates for pyrotinib and pyrotinib maleate.
  • Patent WO2006127205 reports the substitution reaction of 3-chloro-4-nitrobenzene and 2-pyridinemethanol as raw materials, and reduction under zinc powder conditions to generate N-(3-chloro-4-(2-pyridylmethoxy)aniline , and then condensation reaction with ethyl cyanoacetate at high temperature to prepare the synthetic route of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, but the reaction temperature Higher (120°C-125°C), more impurities, lower yield ( ⁇ 30%), which is not conducive to industrial production.
  • Chinese patent CN108084085A discloses the use of 3-chloro-4-fluoroaniline and cyanoacetic acid for condensation Reaction, and then substitution reaction with 2-pyridinemethanol under strongly alkaline conditions to prepare N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide; but this method
  • the condensation reaction of 3-chloro-4-fluoroaniline and cyanoacetic acid is easy to occur, and the activity of the generated intermediate is greatly reduced when the substitution reaction occurs, and the amide is easy to hydrolyze under alkaline conditions, and the yield is low.
  • the present invention provides a preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, which method uses 3-chloro-4-fluorine Nitrobenzene and 2-pyridinemethanol are used as raw materials, and a substitution reaction occurs under alkaline conditions.
  • the solvent I includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene, and acetonitrile is preferably used;
  • the inorganic base includes at least one of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate and potassium carbonate, and potassium hydroxide is preferably used;
  • the molar ratio of the 2-pyridinemethanol (I) and 3-chloro-4-fluoronitrobenzene (II) is 1.03 to 1.2:1;
  • the molar ratio of the inorganic base to 3-chloro-4-fluoronitrobenzene (II) is 1.1 to 1.4:1;
  • the volume ratio of ethanol to water in the ethanol aqueous solution is 3 to 5:1.
  • the acid includes at least one of commercially available hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid and formic acid, preferably hydrochloric acid is used;
  • the molar ratio of the acid to the substrate N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) is 2 to 4:1;
  • the molar ratio of the reduced iron powder to the substrate N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) is 3 to 6:1;
  • the solvent II includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene, and tetrahydrofuran is preferably used;
  • the volume to mass ratio (m/v) of the solvent II described in the above steps to the substrate N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) is 5 to 12:1, and the mass to volume ratio The unit is mL/g.
  • the molar ratio of the cyanoacetic acid (V) and N-(3-chloro-4-(2-pyridinemethoxy)aniline (IV) is 1.1 to 1.6:1;
  • the molar ratio of the condensation agent to the substrate N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) is 1.1 to 1.6:1;
  • the condensation agent includes dicyclohexylcarbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) and 1,3-diisopropyl At least one of carbodiimides (DIC); the condensation agent used and the urea generated after condensation are soluble in water, preferably 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide is used Imine hydrochloride (EDCI).
  • DCC dicyclohexylcarbodiimide
  • EDCI 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
  • DIC 1,3-diisopropyl
  • DIC 1,3-diisopropyl
  • the condensation agent used and the urea generated after condensation are soluble in water, preferably 1-(3-dimethylaminopropyl)-3-ethylcar
  • the preparation method provided by the invention has the following beneficial effects:
  • the reaction route of the present invention uses 3-chloro-4-fluoronitrobenzene and 2-pyridinemethanol as raw materials, under alkaline conditions A substitution reaction occurs under the conditions. After the reaction is completed, it is suction filtered. The product in the filter cake has high purity and the filtrate is a single solvent, which is easy to recycle. After the filter cake is slurried with water, the inorganic salts and slight excess alkali in the product are removed; due to N-(3 -Chloro-4-(2-pyridylmethoxy)nitrobenzene has low solubility in organic solvents and water, but has high solubility in mixed solvents of organic solvents and water.
  • reaction yield is higher than that of 3-chloro-4 reported in WO2006127205 -After the substitution reaction of nitrobenzene and 2-pyridine benzyl alcohol is completed, the crystallization yield by adding water is significantly higher, and the mother liquor is easy to recover.
  • N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene is reduced iron powder, which is cheaper, easier to obtain and safer than zinc powder;
  • the solvent used is a mixture of water and ethanol The solvent has a mild reduction temperature; after the reaction is completed, filter with suction, the filtrate is concentrated in ethanol, filter with suction, and the filter cake is dried to obtain N-(3-chloro-4-(2-pyridylmethoxy)aniline, with high purity of 96% above;
  • the condensation agent used in the condensation reaction is DCC, EDCI, DCI, etc.
  • the insoluble matter is removed by suction filtration, and the solvent is concentrated and removed, and water is added for crystallization to obtain N-(3-chloro-4-(2-pyridinemethoxy)) Phenyl)-2-cyanoacetamide; compared with the high-temperature preparation route disclosed in patent WO2006127205, the reaction is milder, and the crystallized solid has higher purity and higher yield.
  • Figure 1 is a high performance liquid chromatogram of intermediate III prepared in Example 1;
  • Figure 2 is a high performance liquid chromatogram of intermediate IV prepared in Example 2;
  • Figure 3 is a high performance liquid chromatogram of the target product VI prepared in Example 3;
  • Figure 4 is a 1H-NMR pattern of the target product intermediate VI prepared in Example 3.
  • Figure 5 is a high performance liquid chromatogram of the target product VI prepared in Example 4.
  • the raw materials 3-chloro-4-fluoronitrobenzene (II) and 2-pyridinemethanol (I) were purchased from Shanghai Bide Pharmaceutical Technology Co., Ltd.; cyanoacetic acid (V) was purchased from Shanghai McLean Biochemical Technology Co., Ltd.; reduced iron The powder was purchased from Xilong Science Co., Ltd.
  • the filtrate is cooled to room temperature. Concentrate under reduced pressure at 40°C on a rotary evaporator until almost no liquid flows out. Add 140 mL of aqueous solution to the concentrate. , keep stirring at 5°C to crystallize for more than 2h, filter with suction, wash the filter cake with a little ethyl acetate, take a sample for NMR detection, and blast dry the filter cake at 60°C for more than 12h to get brown solid N-(3-chloro-4-( 4.5g of 2-pyridylmethoxy)phenyl)-2-cyanoacetamide (VI), the yield is 52.1%, and the purity is 96.60%.
  • EDCI 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

Provided is a method for preparing a pharmaceutical intermediate N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide. The method comprises: taking 3-chloro-4-fluoronitrobenzene and 2-pyridinemethanol as raw materials for a substitution reaction under an alkaline condition to generate N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene; then under an acidic condition, performing reduction using iron powder to generate N-(3-chloro-4-(2-pyridylmethoxy)aniline; and then performing a condensation reaction on the N-(3-chloro-4-(2-pyridylmethoxy)aniline and cyanoacetic acid under the condition of a condensing agent to generate the N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide. The method is simple to operate, mild in condition, and suitable for large-scale industrial production.

Description

N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法Preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide
本申请要求于2022年03月15日提交中国专利局、申请号为202210251646.1、发明名称为“N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application is required to be submitted to the China Patent Office on March 15, 2022. The application number is 202210251646.1 and the invention name is “N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoethyl The priority of the Chinese patent application "Method for Preparing Amides", the entire content of which is incorporated into this application by reference.
技术领域Technical field
本发明属于药物化学领域,具体涉及一种医药中间体N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法。The invention belongs to the field of medicinal chemistry, and specifically relates to a preparation method of pharmaceutical intermediate N-(3-chloro-4-(2-pyridinemethoxy)phenyl)-2-cyanoacetamide.
背景技术Background technique
N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺(CAS:915945-31-2)是HER-2受体酪氨酸激酶抑制剂来那替尼和马来酸吡咯替尼的重要医药中间体。专利WO2006127205报道了3-氯-4-硝基苯和2-吡啶甲醇为原料进行取代反应,在锌粉条件下还原,生成N-(3-氯-4-(2-吡啶甲氧基)苯胺,然后和氰基乙酸乙酯在高温下缩合反应制备N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的合成路线,但该反应反应温度较高(120℃-125℃),杂质较多,收率较低(<30%),不利于工业生产。中国专利CN108084085A则公开了利用3-氯-4-氟苯胺和氰基乙酸发生缩合反应,然后和2-吡啶甲醇在强碱性条件下取代反应,制备N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的方法;但该反应3-氯-4-氟苯胺和氰基乙酸缩合反应易于发生,生成的中间体发生取代反应时活性大幅降低,且酰胺在碱性条件下易于水解,收率低。N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide (CAS: 915945-31-2) is a HER-2 receptor tyrosine kinase inhibitor Important pharmaceutical intermediates for pyrotinib and pyrotinib maleate. Patent WO2006127205 reports the substitution reaction of 3-chloro-4-nitrobenzene and 2-pyridinemethanol as raw materials, and reduction under zinc powder conditions to generate N-(3-chloro-4-(2-pyridylmethoxy)aniline , and then condensation reaction with ethyl cyanoacetate at high temperature to prepare the synthetic route of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, but the reaction temperature Higher (120℃-125℃), more impurities, lower yield (<30%), which is not conducive to industrial production. Chinese patent CN108084085A discloses the use of 3-chloro-4-fluoroaniline and cyanoacetic acid for condensation Reaction, and then substitution reaction with 2-pyridinemethanol under strongly alkaline conditions to prepare N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide; but this method The condensation reaction of 3-chloro-4-fluoroaniline and cyanoacetic acid is easy to occur, and the activity of the generated intermediate is greatly reduced when the substitution reaction occurs, and the amide is easy to hydrolyze under alkaline conditions, and the yield is low.
发明内容Contents of the invention
针对上述问题,本发明提供一种N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,该方法以3-氯-4-氟硝基苯和2-吡啶甲醇为原料,在碱性条件下发生取代反应,反应完成后,抽滤,滤饼在水溶液中打浆,抽滤后干燥,得高收率、高纯度N-(3-氯-4-(2-吡啶甲氧基)硝基苯;N-(3-氯-4-(2-吡啶甲氧基)硝基苯在乙醇和水的混合溶剂中,加入酸和还原铁粉,反应完成后,抽滤,舍弃滤饼,滤液减压浓缩除去乙醇,降至室温后,抽滤,滤饼干 燥,得高收率和高纯度N-(3-氯-4-(2-吡啶甲氧基)苯胺;再利用N-(3-氯-4-(2-吡啶甲氧基)苯胺和氰基乙酸在缩合剂作用下,发生缩合反应,反应完成后,趁热抽滤,浓缩溶剂后加水低温析晶,得目标产物N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺,该制备路线反应温和,收率高,易于工业化生产。In view of the above problems, the present invention provides a preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, which method uses 3-chloro-4-fluorine Nitrobenzene and 2-pyridinemethanol are used as raw materials, and a substitution reaction occurs under alkaline conditions. After the reaction is completed, suction filtration is performed, the filter cake is beaten in an aqueous solution, and dried after suction filtration to obtain high yield and high purity N-(3 -Chloro-4-(2-pyridylmethoxy)nitrobenzene; N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene) In a mixed solvent of ethanol and water, add acid and reduce Iron powder, after the reaction is completed, filter with suction and discard the filter cake. The filtrate is concentrated under reduced pressure to remove ethanol. After cooling to room temperature, filter with suction and filter the cake. Drying to obtain high yield and high purity N-(3-chloro-4-(2-pyridylmethoxy)aniline; then use N-(3-chloro-4-(2-pyridylmethoxy)aniline and cyanide Acetic acid undergoes a condensation reaction under the action of a condensing agent. After the reaction is completed, filter while it is hot, concentrate the solvent and add water for low-temperature crystallization to obtain the target product N-(3-chloro-4-(2-pyridylmethoxy)benzene. base)-2-cyanoacetamide, this preparation route has mild reaction, high yield, and is easy for industrial production.
具体的说,本申请通过以下的技术路线来实现的:Specifically, this application is implemented through the following technical routes:
一种N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其制备步骤如下:A preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, the preparation steps are as follows:
1)3-氯-4-氟硝基苯(II)和2-吡啶甲醇(I)溶解在溶剂I中,加入固体的无机碱,在碱性条件下,30-50℃发生取代反应后,抽滤,取滤饼在水溶液中打浆,再次抽滤,60℃鼓风干燥后获得N-(3-氯-4-(2-吡啶甲氧基)硝基苯(III);1) Dissolve 3-chloro-4-fluoronitrobenzene (II) and 2-pyridinemethanol (I) in solvent I, add solid inorganic base, and after a substitution reaction occurs at 30-50°C under alkaline conditions, Perform suction filtration, take the filter cake and beat it in the aqueous solution, suction filtrate again, and obtain N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) after air drying at 60°C;
所述溶剂I包括四氢呋喃,甲基四氢呋喃,乙腈,乙酸乙酯,甲基叔丁基醚和甲苯中的至少一种,优选使用乙腈;The solvent I includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene, and acetonitrile is preferably used;
所述无机碱包括氢氧化钠,氢氧化钾,氢氧化锂,碳酸钠和碳酸钾中的至少一种,优选的使用氢氧化钾;The inorganic base includes at least one of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate and potassium carbonate, and potassium hydroxide is preferably used;
所述2-吡啶甲醇(I)与3-氯-4-氟硝基苯(II)的摩尔比为1.03~1.2:1;The molar ratio of the 2-pyridinemethanol (I) and 3-chloro-4-fluoronitrobenzene (II) is 1.03 to 1.2:1;
所述无机碱与3-氯-4-氟硝基苯(II)的摩尔比1.1~1.4:1;The molar ratio of the inorganic base to 3-chloro-4-fluoronitrobenzene (II) is 1.1 to 1.4:1;
2)N-(3-氯-4-(2-吡啶甲氧基)硝基苯(III)溶解于乙醇水溶液中,20-40℃加入酸和还原铁粉反应,反应结束后抽滤,取滤液减压浓缩除去乙醇,降至室温后,再次抽滤,取滤饼干燥后,获得N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV);2) Dissolve N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) in ethanol aqueous solution, add acid and reduced iron powder at 20-40°C to react, filter after the reaction is completed, and take The filtrate is concentrated under reduced pressure to remove ethanol. After cooling to room temperature, it is suction filtered again. After drying the filter cake, N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) is obtained;
所述乙醇水溶液中乙醇与水的体积比为3~5:1。The volume ratio of ethanol to water in the ethanol aqueous solution is 3 to 5:1.
所述酸包括市售盐酸,硫酸,磷酸,醋酸和甲酸中的至少一种,优选的使用盐酸;The acid includes at least one of commercially available hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid and formic acid, preferably hydrochloric acid is used;
所述酸与底物N-(3-氯-4-(2-吡啶甲氧基)硝基苯(III)摩尔比为2~4:1;The molar ratio of the acid to the substrate N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) is 2 to 4:1;
所述还原铁粉与底物N-(3-氯-4-(2-吡啶甲氧基)硝基苯(III)摩尔比为3~6:1;The molar ratio of the reduced iron powder to the substrate N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene (III) is 3 to 6:1;
3)将N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV)和氰基乙酸(V)溶解在溶剂II中,加入缩合剂,40-70℃发生缩合反应,反应结束后趁热抽滤,除去固体不溶物,取滤液浓缩,获得浓缩物;浓缩物中物加适量水后,0-10℃析晶,即获得N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺(VI); 3) Dissolve N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) and cyanoacetic acid (V) in solvent II, add a condensing agent, and a condensation reaction will occur at 40-70°C. After completion, suction filtration while hot removes solid insoluble matter, and the filtrate is concentrated to obtain a concentrate; after adding an appropriate amount of water to the concentrate, crystallize at 0-10°C to obtain N-(3-chloro-4-(2- Pyridylmethoxy)phenyl)-2-cyanoacetamide (VI);
所述溶剂II包括四氢呋喃,甲基四氢呋喃,乙腈,乙酸乙酯,甲基叔丁基醚和甲苯中的至少一种,优选使用四氢呋喃;The solvent II includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene, and tetrahydrofuran is preferably used;
上述步骤所述溶剂II与底物N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV)体积质量比(m/v)为5~12:1,所述质量体积比的单位是mL/g。The volume to mass ratio (m/v) of the solvent II described in the above steps to the substrate N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) is 5 to 12:1, and the mass to volume ratio The unit is mL/g.
所述氰基乙酸(V)与N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV)的摩尔比为1.1~1.6:1;The molar ratio of the cyanoacetic acid (V) and N-(3-chloro-4-(2-pyridinemethoxy)aniline (IV) is 1.1 to 1.6:1;
所述缩合剂与底物N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV)的摩尔比为1.1~1.6:1;The molar ratio of the condensation agent to the substrate N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) is 1.1 to 1.6:1;
所述缩合剂包括二环己基碳二亚胺(DCC)、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDCI)和1,3-二异丙基碳二亚胺(DIC)中的至少一种;所用缩合剂及其缩合后生成的脲可溶于水,优选的使用1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDCI)。The condensation agent includes dicyclohexylcarbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) and 1,3-diisopropyl At least one of carbodiimides (DIC); the condensation agent used and the urea generated after condensation are soluble in water, preferably 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide is used Imine hydrochloride (EDCI).
以上反应涉及的化学方程式如下:
The chemical equation involved in the above reaction is as follows:
与现有N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺制备方法相比,本发明所提供的制备方法具有以下有益效果:Compared with the existing preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, the preparation method provided by the invention has the following beneficial effects:
1)本发明反应路线以3-氯-4-氟硝基苯和2-吡啶甲醇为原料,在碱性条件 下发生取代反应,反应完成后,抽滤,滤饼中产品纯度较高,滤液为单一溶剂,易于回收利用;滤饼用水打浆后除去产品中的无机盐和稍许过量碱;由于N-(3-氯-4-(2-吡啶甲氧基)硝基苯在有机溶剂和水中溶解度均较小,在有机溶剂和水混合溶剂中溶解度较大,反应收率较WO2006127205报导的3-氯-4-硝基苯和2-吡啶苄醇取代反应完成后,加水析晶收率明显较高,且母液易于回收。1) The reaction route of the present invention uses 3-chloro-4-fluoronitrobenzene and 2-pyridinemethanol as raw materials, under alkaline conditions A substitution reaction occurs under the conditions. After the reaction is completed, it is suction filtered. The product in the filter cake has high purity and the filtrate is a single solvent, which is easy to recycle. After the filter cake is slurried with water, the inorganic salts and slight excess alkali in the product are removed; due to N-(3 -Chloro-4-(2-pyridylmethoxy)nitrobenzene has low solubility in organic solvents and water, but has high solubility in mixed solvents of organic solvents and water. The reaction yield is higher than that of 3-chloro-4 reported in WO2006127205 -After the substitution reaction of nitrobenzene and 2-pyridine benzyl alcohol is completed, the crystallization yield by adding water is significantly higher, and the mother liquor is easy to recover.
2)N-(3-氯-4-(2-吡啶甲氧基)硝基苯所用还原剂为还原铁粉,较锌粉价格低廉,易得,安全性好;所用溶剂为水和乙醇混合溶剂,还原温度温和;反应完成后,抽滤,滤液浓缩乙醇后,抽滤,滤饼干燥得N-(3-氯-4-(2-吡啶甲氧基)苯胺,纯度高,达96%以上;2) The reducing agent used in N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene is reduced iron powder, which is cheaper, easier to obtain and safer than zinc powder; the solvent used is a mixture of water and ethanol The solvent has a mild reduction temperature; after the reaction is completed, filter with suction, the filtrate is concentrated in ethanol, filter with suction, and the filter cake is dried to obtain N-(3-chloro-4-(2-pyridylmethoxy)aniline, with high purity of 96% above;
3)缩合反应所用缩合剂为DCC,EDCI,DCI等,缩合完成,抽滤除去不溶物,浓缩除去溶剂加入水析晶,得N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺;较专利WO2006127205所公开的高温制备路线反应温和,析晶出固体纯度较高,收率较高。3) The condensation agent used in the condensation reaction is DCC, EDCI, DCI, etc. After the condensation is completed, the insoluble matter is removed by suction filtration, and the solvent is concentrated and removed, and water is added for crystallization to obtain N-(3-chloro-4-(2-pyridinemethoxy)) Phenyl)-2-cyanoacetamide; compared with the high-temperature preparation route disclosed in patent WO2006127205, the reaction is milder, and the crystallized solid has higher purity and higher yield.
附图说明Description of the drawings
附图1为实施例1中制备中间体III高效液相色谱图;Figure 1 is a high performance liquid chromatogram of intermediate III prepared in Example 1;
附图2为实施例2中制备中间体IV高效液相色谱图;Figure 2 is a high performance liquid chromatogram of intermediate IV prepared in Example 2;
附图3为实施例3中制备的目标产物VI高效液相色谱图;Figure 3 is a high performance liquid chromatogram of the target product VI prepared in Example 3;
附图4为实施例3制备的目标产物中间体VI的1H-NMR图;Figure 4 is a 1H-NMR pattern of the target product intermediate VI prepared in Example 3;
附图5为实施例4制备的目标产物VI的高效液相色谱图。Figure 5 is a high performance liquid chromatogram of the target product VI prepared in Example 4.
具体实施方式Detailed ways
除非特别说明,以下实施例使用的原料和试剂均为市售。Unless otherwise stated, the raw materials and reagents used in the following examples are all commercially available.
原料3-氯-4-氟硝基苯(II)和2-吡啶甲醇(I)购自上海毕得医药科技有限公司;氰基乙酸(V)购自上海麦克林生化科技有限公司;还原铁粉购自西陇科学股份有限公司。The raw materials 3-chloro-4-fluoronitrobenzene (II) and 2-pyridinemethanol (I) were purchased from Shanghai Bide Pharmaceutical Technology Co., Ltd.; cyanoacetic acid (V) was purchased from Shanghai McLean Biochemical Technology Co., Ltd.; reduced iron The powder was purchased from Xilong Science Co., Ltd.
实施例1Example 1
3000mL反应瓶中加入1000mL乙腈,34.3g(0.314mol)2-吡啶甲醇(I),搅拌,加入21.0g(0.375mol)氢氧化钾,52.7g(0.30mol)3-氯-4-氟硝基苯(II),升温至40℃,保温反应24h以上,TLC检测(乙酸乙酯:正己烷=1:1,原料 3-氯-4-氟硝基苯几乎无剩余),反应完毕后,降温至5℃,保温搅拌(100转/分钟,下同)2h以上,抽滤,滤饼用200mL水打浆后再次抽滤,滤饼60℃鼓风干燥12h以上,得淡黄色固体N-(3-氯-4-(2-吡啶甲氧基)硝基苯76.2g,收率为96.0%,高效液相检测其纯度96.47%。(液相色谱条件:Agilent 1260 infinity II,WondaSil C18 Superb(4.6×250mm,5um),流动相:磷酸二氢钠缓冲液,三乙胺调节pH6.1,波长233nm,柱温35℃,流速1.0mL/min,下同),其液相色谱图如图1所示。Add 1000mL acetonitrile, 34.3g (0.314mol) 2-pyridinemethanol (I) into the 3000mL reaction bottle, stir, add 21.0g (0.375mol) potassium hydroxide, 52.7g (0.30mol) 3-chloro-4-fluoronitro Benzene (II), raise the temperature to 40°C, keep the reaction for more than 24 hours, and detect by TLC (ethyl acetate: n-hexane = 1:1, raw material 3-Chloro-4-fluoronitrobenzene (almost no residue)), after the reaction is completed, cool to 5°C, keep stirring (100 rpm, the same below) for more than 2 hours, filter with suction, beat the filter cake with 200 mL of water and pump again Filter, and the filter cake is blast dried at 60°C for more than 12 hours to obtain 76.2g of light yellow solid N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene, with a yield of 96.0%. High-performance liquid phase detection of Purity 96.47%. (LC conditions: Agilent 1260 infinity II, WondaSil C18 Superb (4.6×250mm, 5um), mobile phase: sodium dihydrogen phosphate buffer, triethylamine to adjust pH to 6.1, wavelength 233nm, column temperature 35 ℃, flow rate 1.0mL/min, the same below), the liquid chromatogram is shown in Figure 1.
实施例2Example 2
2000mL反应瓶中加入616mL乙醇,154mL水,搅拌后获得乙醇水溶液,加入77g实施例1制备的(0.29mol)N-(3-氯-4-(2-吡啶甲氧基)硝基苯,29mL浓度为37%的盐酸,升温至30℃,缓慢加入81.4g(1.45mol)还原铁粉,保温搅拌1h后,TLC检测(乙酸乙酯:正己烷=1:1,本步骤原料N-(3-氯-4-(2-吡啶甲氧基)硝基苯(III)几乎无剩余),反应完毕后,降温至室温,抽滤,滤饼用稍许乙醇洗涤,舍弃滤饼,滤液旋转蒸发仪50℃减压基本无液体流出,浓缩成粘稠状,然后加入300mL水,5℃搅拌析晶1h以上,抽滤,滤饼60℃鼓风干燥12h以上,得棕褐色固体N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV)61.8g,收率为90.9%,纯度为97.08%。所获得3-氯-4-(吡啶甲氧基)苯胺的液相色谱图如图2所示(色谱参数同实施例1)。Add 616 mL ethanol and 154 mL water to the 2000 mL reaction bottle. After stirring, an ethanol aqueous solution is obtained. Add 77 g (0.29 mol) N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene prepared in Example 1, 29 mL). Hydrochloric acid with a concentration of 37% was heated to 30°C, and 81.4g (1.45mol) reduced iron powder was slowly added. After stirring for 1 hour, TLC detected (ethyl acetate: n-hexane = 1:1, the raw material for this step is N-(3 -Chloro-4-(2-pyridylmethoxy)nitrobenzene (III) with almost no residue), after the reaction is completed, cool to room temperature, filter with suction, wash the filter cake with a little ethanol, discard the filter cake, and use the filtrate rotary evaporator Basically no liquid flows out under reduced pressure at 50°C. Concentrate to a viscous state, then add 300mL of water, stir and crystallize at 5°C for more than 1 hour, filter with suction, and blast dry the filter cake at 60°C for more than 12 hours to obtain a tan solid N-(3- 61.8g of chloro-4-(2-pyridylmethoxy)aniline (IV), yield 90.9%, purity 97.08%. Liquid chromatogram of the obtained 3-chloro-4-(pyridylmethoxy)aniline As shown in Figure 2 (chromatographic parameters are the same as Example 1).
实施例3Example 3
250mL反应瓶中加入70mL四氢呋喃,7.0g(0.03mol)实施例2制备的N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV),3.0g(0.035mol)氰基乙酸,7.2g(0.035mol)二环己基碳二亚胺,升温至66℃保温反应1h后,TLC检测(乙酸乙酯:正己烷=1:1,本步骤原料3-氯-4-(吡啶甲氧基)苯胺(IV)几乎无剩余,下同),反应完毕后,趁热抽滤,滤液降温至室温,旋转蒸发仪40℃减压浓缩至基本无液体流出,向浓缩物中加入140mL水溶液,5℃保温搅拌析晶2h以上,抽滤,滤饼用稍许乙酸乙酯洗涤,取样品核磁检测,滤饼60℃鼓风干燥12h以上,得棕色固体N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺(VI)4.5g,收率为52.1%,纯度为96.60%。其液相色谱如图3所示,1H-NMR图如图4所示,核磁图谱确认为目标产物N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰 胺(VI)。Add 70 mL tetrahydrofuran, 7.0 g (0.03 mol) N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) prepared in Example 2, and 3.0 g (0.035 mol) cyanoacetic acid into the 250 mL reaction bottle. , 7.2g (0.035mol) dicyclohexylcarbodiimide, heated to 66°C and incubated for 1 hour, then TLC detected (ethyl acetate: n-hexane = 1:1, the raw material for this step is 3-chloro-4-(pyridinemethyl) There is almost no residue of oxy)aniline (IV), the same below). After the reaction is completed, filter while it is hot. The filtrate is cooled to room temperature. Concentrate under reduced pressure at 40°C on a rotary evaporator until almost no liquid flows out. Add 140 mL of aqueous solution to the concentrate. , keep stirring at 5℃ to crystallize for more than 2h, filter with suction, wash the filter cake with a little ethyl acetate, take a sample for NMR detection, and blast dry the filter cake at 60℃ for more than 12h to get brown solid N-(3-chloro-4-( 4.5g of 2-pyridylmethoxy)phenyl)-2-cyanoacetamide (VI), the yield is 52.1%, and the purity is 96.60%. Its liquid chromatography is shown in Figure 3, and its 1H-NMR chart is shown in Figure 3. As shown in 4, the NMR spectrum was confirmed to be the target product N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetyl Amine(VI).
实施例4Example 4
1000mL反应瓶中加入470mL四氢呋喃,搅拌,向反应瓶中加入46.9g(0.20mol)实施例2制备的N-(3-氯-4-(2-吡啶甲氧基)苯胺(IV),23.8g(0.28mol)氰基乙酸,53.7g(0.28mol)1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐,加毕,升温至66℃保温反应1h,TLC检测,反应完毕后,趁热抽滤,滤液降温至室温,滤液旋转蒸发仪40℃减压浓缩至基本无液体流出,加入470mL水,5℃搅拌2h以上,抽滤,滤饼用稍许乙醇洗涤,滤饼60℃鼓风干燥12h以上,得棕色固体N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺(VI)42.3g,收率为73.5%,纯度为99.25%。其液相色谱如图5所示。Add 470 mL tetrahydrofuran to the 1000 mL reaction flask, stir, and add 46.9 g (0.20 mol) of N-(3-chloro-4-(2-pyridylmethoxy)aniline (IV) prepared in Example 2 to the reaction flask, 23.8 g (0.28mol) cyanoacetic acid, 53.7g (0.28mol) 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, complete the addition, heat to 66°C and incubate for 1 hour, TLC After detection and reaction, filter while hot, cool the filtrate to room temperature, and concentrate the filtrate under reduced pressure using a rotary evaporator at 40°C until almost no liquid flows out. Add 470mL of water, stir at 5°C for more than 2 hours, filter with suction, and wash the filter cake with a little ethanol. , the filter cake was air-dried at 60°C for more than 12 hours to obtain 42.3g of brown solid N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide (VI), with a yield of 73.5%, and the purity is 99.25%. Its liquid chromatography is shown in Figure 5.
可见,1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDCI)为缩合剂较二环己基碳二亚胺(DCC)收率和纯度均显著提高。It can be seen that using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) as the condensation agent significantly improves the yield and purity compared with dicyclohexylcarbodiimide (DCC).
以上所述的具体实施方式,对本发明的目的、技术方案和有益效果进行了进一步详细说明,所应理解的是,以上所述仅为本发明的具体实施方式而已,并不用于限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。 The above-mentioned specific embodiments further describe the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above-mentioned are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection scope of the present invention.

Claims (10)

  1. 一种N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤如下:A preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide, which is characterized in that the steps are as follows:
    1)将3-氯-4-氟硝基苯和2-吡啶甲醇溶解在溶剂I中,加入无机碱,30-50℃发生取代反应后,抽滤;取滤饼打浆后再次抽滤,干燥后获得N-(3-氯-4-(2-吡啶甲氧基)硝基苯;1) Dissolve 3-chloro-4-fluoronitrobenzene and 2-pyridinemethanol in solvent I, add an inorganic base, and after a substitution reaction occurs at 30-50°C, suction filter; take the filter cake, beat it, suction filter again, and dry. Finally, N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene is obtained;
    所述溶剂I包括四氢呋喃、甲基四氢呋喃、乙腈、乙酸乙酯、甲基叔丁基醚和甲苯中的至少一种;The solvent I includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene;
    所用无机碱包括氢氧化钠、氢氧化钾、氢氧化锂、碳酸钠和碳酸钾中的至少一种;The inorganic base used includes at least one of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate and potassium carbonate;
    2)将步骤1)获得的N-(3-氯-4-(2-吡啶甲氧基)硝基苯溶解于乙醇水溶液中,加入酸和还原铁粉,反应结束后抽滤,取滤液减压浓缩除去乙醇,再次抽滤,取滤饼干燥后,获得N-(3-氯-4-(2-吡啶甲氧基)苯胺;2) Dissolve the N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene obtained in step 1) in an aqueous ethanol solution, add acid and reduced iron powder, filter after the reaction is completed, and take the filtrate to reduce Concentrate under pressure to remove ethanol, filter again with suction, and dry the filter cake to obtain N-(3-chloro-4-(2-pyridylmethoxy)aniline;
    所述酸包括盐酸、硫酸、磷酸、醋酸和甲酸中的至少一种;The acid includes at least one of hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid and formic acid;
    3)将步骤2)获得的N-(3-氯-4-(2-吡啶甲氧基)苯胺和氰基乙酸溶解在溶剂II中,加入缩合剂进行缩合反应,缩合反应结束后抽滤,取滤液浓缩;取浓缩物加水后于0-10℃析晶,即获得N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺;3) Dissolve N-(3-chloro-4-(2-pyridylmethoxy)aniline and cyanoacetic acid obtained in step 2) in solvent II, add a condensing agent to perform a condensation reaction, and filter with suction after the condensation reaction is completed. Take the filtrate and concentrate; add water to the concentrate and crystallize at 0-10°C to obtain N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide;
    所述溶剂II包括四氢呋喃、甲基四氢呋喃、乙腈、乙酸乙酯、甲基叔丁基醚和甲苯中的至少一种;The solvent II includes at least one of tetrahydrofuran, methyltetrahydrofuran, acetonitrile, ethyl acetate, methyl tert-butyl ether and toluene;
    所述缩合剂包括二环己基碳二亚胺、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和1,3-二异丙基碳二亚胺中的至少一种。The condensation agent includes dicyclohexylcarbodiimide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 1,3-diisopropylcarbodiimide. of at least one.
  2. 根据权利要求1所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤1)中,所述无机碱与3-氯-4-氟硝基苯的摩尔比1.1~1.4:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, characterized in that, in step 1), the inorganic base The molar ratio to 3-chloro-4-fluoronitrobenzene is 1.1~1.4:1.
  3. 根据权利要求1或2所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤1)中,所述2-吡啶甲醇与3-氯-4-氟硝基苯的摩尔比为1.03~1.2:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1 or 2, characterized in that in step 1), the The molar ratio of 2-pyridinemethanol and 3-chloro-4-fluoronitrobenzene is 1.03 to 1.2:1.
  4. 根据权利要求1所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤2)中,所述乙醇水溶液中,乙醇与水的体积比 为3~5:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, characterized in that, in step 2), the ethanol aqueous solution , the volume ratio of ethanol to water It is 3~5:1.
  5. 根据权利要求1所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤2)中,所述酸与N-(3-氯-4-(2-吡啶甲氧基)硝基苯的摩尔比为2~4:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, characterized in that in step 2), the acid and The molar ratio of N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene is 2 to 4:1.
  6. 根据权利要求1或5所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤2)中,所述还原铁粉与N-(3-氯-4-(2-吡啶甲氧基)硝基苯的摩尔比为3~6:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1 or 5, characterized in that in step 2), the The molar ratio of reduced iron powder to N-(3-chloro-4-(2-pyridylmethoxy)nitrobenzene is 3 to 6:1.
  7. 根据权利要求1所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤3)中,所述溶剂II与N-(3-氯-4-(2-吡啶甲氧基)苯胺的体积质量比为5~12:1,所述质量体积比的单位是mL/g。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, characterized in that in step 3), the solvent II The volume to mass ratio with N-(3-chloro-4-(2-pyridylmethoxy)aniline is 5 to 12:1, and the unit of the mass to volume ratio is mL/g.
  8. 根据权利要求1所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤3)中,所述氰基乙酸与N-(3-氯-4-(2-吡啶甲氧基)苯胺的摩尔比为1.1~1.6:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, characterized in that, in step 3), the cyano group The molar ratio of acetic acid to N-(3-chloro-4-(2-pyridylmethoxy)aniline is 1.1 to 1.6:1.
  9. 根据权利要求1、7或8所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤3)中,所述缩合剂与N-(3-氯-4-(2-吡啶甲氧基)苯胺的摩尔比为1.1~1.6:1。The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, 7 or 8, characterized in that, in step 3), The molar ratio of the condensation agent to N-(3-chloro-4-(2-pyridylmethoxy)aniline is 1.1 to 1.6:1.
  10. 根据权利要求1、7或8所述N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法,其特征在于,步骤3)中,所述缩合反应的温度为40~70℃。 The preparation method of N-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide according to claim 1, 7 or 8, characterized in that, in step 3), The temperature of the condensation reaction is 40-70°C.
PCT/CN2023/094292 2022-03-15 2023-05-15 Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide WO2023174449A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210251646.1 2022-03-15
CN202210251646.1A CN114736154B (en) 2022-03-15 2022-03-15 Process for preparing N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Publications (1)

Publication Number Publication Date
WO2023174449A1 true WO2023174449A1 (en) 2023-09-21

Family

ID=82275612

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/094292 WO2023174449A1 (en) 2022-03-15 2023-05-15 Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide

Country Status (2)

Country Link
CN (1) CN114736154B (en)
WO (1) WO2023174449A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114736154B (en) * 2022-03-15 2023-07-21 安庆朗坤药业有限公司 Process for preparing N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101180269A (en) * 2005-05-25 2008-05-14 惠氏公司 Method of preparing 3-cyano-quinolines and intermediates made thereby
CN101448840A (en) * 2006-03-20 2009-06-03 拜耳医药保健股份公司 Tetrahydropyridothienopyrimidine compounds and methods of use thereof
CN102625797A (en) * 2009-06-25 2012-08-01 迈德药物研发技术有限公司 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
CN114736154A (en) * 2022-03-15 2022-07-12 安庆朗坤药业有限公司 Preparation method of N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786437A (en) * 2012-09-06 2012-11-21 中国药科大学 Preparation method of teriflunomide
CN108084085B (en) * 2017-12-28 2019-11-26 山东铂源药业有限公司 A kind of preparation method of N- (the chloro- 4- of 3- (2- pyridomethoxy) phenyl) -2- cyanoacetamide
CN110818619B (en) * 2019-12-13 2021-03-02 山东铂源药业有限公司 Synthetic method of N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101180269A (en) * 2005-05-25 2008-05-14 惠氏公司 Method of preparing 3-cyano-quinolines and intermediates made thereby
CN101448840A (en) * 2006-03-20 2009-06-03 拜耳医药保健股份公司 Tetrahydropyridothienopyrimidine compounds and methods of use thereof
CN102625797A (en) * 2009-06-25 2012-08-01 迈德药物研发技术有限公司 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
CN114736154A (en) * 2022-03-15 2022-07-12 安庆朗坤药业有限公司 Preparation method of N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Also Published As

Publication number Publication date
CN114736154B (en) 2023-07-21
CN114736154A (en) 2022-07-12

Similar Documents

Publication Publication Date Title
CN111423452B (en) Intermediate of Rayleigh Lu Geli and preparation method and application thereof
CN111333633A (en) Rugosril intermediate compound and preparation method and application thereof
CN104829523B (en) Rui Gefeini salt and its crystal formation, preparation method
WO2023174449A1 (en) Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide
CN111646922B (en) Synthetic method of 2- (4-bromo-2-cyano-6-fluorophenyl) acetic acid
CN109824590B (en) Preparation method of Lovatinib and salt thereof
CN104884427A (en) Compounds useful in the synthesis of benzamide compounds
CN112851646A (en) Preparation method of Tegolrazan
CN104736540B (en) The preparation method of pemetrexed and its lysine salt
CN109988077A (en) A kind of synthetic method and intermediate of A Palu amine
CN107573264A (en) A kind of preparation technology of the sulfonic acid chloride of 3 cyano group, 5 methoxybenzene 1
CN108440409B (en) Green and efficient preparation method of rebamipide
WO2021238963A1 (en) Preparation method for (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)methyl propionate diacid salt
WO2021077351A1 (en) Method for preparing telmisartan impurity j
CN106543144B (en) A kind of industrialized process for preparing of dabigatran etcxilate
CN104311485A (en) Preparation method of medicine bosutinib for treating leukemia
CN104080770A (en) An improved process for the preparation of roflumilast
CN101805265B (en) Synthesis method of 2-nitro-4-substituted phenylacetic acid
CN108329218B (en) Preparation method of (R) -epinephrine
CN111233839B (en) (E) 1-acyl-2- (2- (9-alkyl) carbazole-3-) vinyl-benzimidazole and preparation method thereof
CN104163778B (en) A kind of method preparing p-amino-benzamidine hydrochloride
CN102993116A (en) Preparation method of benzoxazine excitant
CN106810452A (en) A kind of preparation method of cinacalcet hydrochloride
CN114181117A (en) Preparation method of peramivir intermediate
TW200530168A (en) Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23769951

Country of ref document: EP

Kind code of ref document: A1